Abstract
Dexamethasone acetate (9α-fluoro-16α-methyl11β,17,21-trihydroxy-1,4-pregnadiene-3,20-dione 21acetate, DMA hereafter) (Fig 1) is an active pharmaceutical ingredient frequently used as an antiinflammatory against rheumatism pains, asthma or even cancer pains. This molecule presents an original behavior during its crystallization in specific conditions. For example, an ethanolic saturated solution of DMA injected in water (anti-solvent) [1] leads to the formation of hollow needlelike crystals called whiskers. At present, the mechanism of formation of these “whiskers” remains not fully understood [1, 2].
Highlights
IntroductionDexamethasone acetate (9α-fluoro-16α-methyl11β,17,21-trihydroxy-1,4-pregnadiene-3,20-dione 21acetate, DMA hereafter) (Fig 1) is an active pharmaceutical ingredient frequently used as an antiinflammatory against rheumatism pains, asthma or even cancer pains
Dexamethasone acetate (9α-fluoro-16α-methyl11β,17,21-trihydroxy-1,4-pregnadiene-3,20-dione 21acetate, DMA hereafter) (Fig 1) is an active pharmaceutical ingredient frequently used as an antiinflammatory against rheumatism pains, asthma or even cancer pains.This molecule presents an original behavior during its crystallization in specific conditions
The stability of DMA solid phases were investigated with the help of X-Ray powder diffraction under variable temperature and relative humidity [3], single crystal XRay diffraction, Dynamic Vapor Sorption [4,5,6] and TGDSC
Summary
Dexamethasone acetate (9α-fluoro-16α-methyl11β,17,21-trihydroxy-1,4-pregnadiene-3,20-dione 21acetate, DMA hereafter) (Fig 1) is an active pharmaceutical ingredient frequently used as an antiinflammatory against rheumatism pains, asthma or even cancer pains. This molecule presents an original behavior during its crystallization in specific conditions. An ethanolic saturated solution of DMA injected in water (anti-solvent) [1] leads to the formation of hollow needlelike crystals called whiskers. The mechanism of formation of these “whiskers” remains not fully understood [1, 2]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.